Please assess the completion status of the following clinical trial:

Trial Title: Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Migraine with aura patients of both sexes.~* 18-60 years.~* 50-100 kg.~Exclusion Criteria:~* Headache less than 48 hours before the tests start~* Daily consumption of drugs of any kind other than oral contraceptives~* Pregnant or nursing women.~* Cardiovascular disease of any kind, including cerebrovascular diseases.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Levcromakalim (Type: ACTIVE_COMPARATOR): None
- Saline (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).